Key Metrics
CiteScore 

8.2
Eigenfactor 

0.005 - 0.01
H-Index 

156
Impact Factor 

< 5
SJR 

Q2Genetics

SNIP 

1.05
Recommended pre-submission checks
Powered by 

Topics Covered on Human Gene Therapy
Human Gene Therapy Journal Specifications
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1990 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Human Gene Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Human Gene Therapy
Exploring Development Options of a Polishing Chromatography Step for AAV7 and AAV8.
- 30 Dec 2025
- Human gene therapy
In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.
- 24 Dec 2025
- Human gene therapy
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China.
- 23 Dec 2025
- Human gene therapy
Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II Mice.
- 16 Dec 2025
- Human gene therapy
Brain-Directed AAV Gene Therapy Rescues a Mouse Model of the CLN5 Form of Neuronal Ceroid Lipofuscinosis Disease and Normalizes a Blood Plasma Biomarker of Neurodegeneration.
- 16 Dec 2025
- Human gene therapy
Efficient LAMA1 Gene Activation by Epigenome Editing as a Therapeutic Approach for LAMA2-CMD.
- 15 Dec 2025
- Human gene therapy
Exploring Development Options of a Polishing Chromatography Step for AAV7 and AAV8.
- 30 Dec 2025
- Human gene therapy
In Remembrance of Professor Zelig Eshhar: A Life Committed to CAR-T.
- 24 Dec 2025
- Human gene therapy
Regulatory Perspective for Biologics License Application of Recombinant Adeno-Associated Virus Products in China.
- 23 Dec 2025
- Human gene therapy
Intravenous Delivery of a Gene Therapy Vector that Expresses an Antitransferrin Receptor 1 Nanobody-I2S Fusion Protein Rescued Central Nervous System Lysosomal Burden in Mucopolysaccharidosis II Mice.
- 16 Dec 2025
- Human gene therapy
Brain-Directed AAV Gene Therapy Rescues a Mouse Model of the CLN5 Form of Neuronal Ceroid Lipofuscinosis Disease and Normalizes a Blood Plasma Biomarker of Neurodegeneration.
- 16 Dec 2025
- Human gene therapy
Efficient LAMA1 Gene Activation by Epigenome Editing as a Therapeutic Approach for LAMA2-CMD.
- 15 Dec 2025
- Human gene therapy